Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 33
Filtrer
1.
Stud Mycol ; 86: 1-28, 2017 Mar.
Article de Anglais | MEDLINE | ID: mdl-28348446

RÉSUMÉ

The order Chaetothyriales (Pezizomycotina, Ascomycetes) harbours obligatorily melanised fungi and includes numerous etiologic agents of chromoblastomycosis, phaeohyphomycosis and other diseases of vertebrate hosts. Diseases range from mild cutaneous to fatal cerebral or disseminated infections and affect humans and cold-blooded animals globally. In addition, Chaetothyriales comprise species with aquatic, rock-inhabiting, ant-associated, and mycoparasitic life-styles, as well as species that tolerate toxic compounds, suggesting a high degree of versatile extremotolerance. To understand their biology and divergent niche occupation, we sequenced and annotated a set of 23 genomes of main the human opportunists within the Chaetothyriales as well as related environmental species. Our analyses included fungi with diverse life-styles, namely opportunistic pathogens and closely related saprobes, to identify genomic adaptations related to pathogenesis. Furthermore, ecological preferences of Chaetothyriales were analysed, in conjuncture with the order-level phylogeny based on conserved ribosomal genes. General characteristics, phylogenomic relationships, transposable elements, sex-related genes, protein family evolution, genes related to protein degradation (MEROPS), carbohydrate-active enzymes (CAZymes), melanin synthesis and secondary metabolism were investigated and compared between species. Genome assemblies varied from 25.81 Mb (Capronia coronata) to 43.03 Mb (Cladophialophora immunda). The bantiana-clade contained the highest number of predicted genes (12 817 on average) as well as larger genomes. We found a low content of mobile elements, with DNA transposons from Tc1/Mariner superfamily being the most abundant across analysed species. Additionally, we identified a reduction of carbohydrate degrading enzymes, specifically many of the Glycosyl Hydrolase (GH) class, while most of the Pectin Lyase (PL) genes were lost in etiological agents of chromoblastomycosis and phaeohyphomycosis. An expansion was found in protein degrading peptidase enzyme families S12 (serine-type D-Ala-D-Ala carboxypeptidases) and M38 (isoaspartyl dipeptidases). Based on genomic information, a wide range of abilities of melanin biosynthesis was revealed; genes related to metabolically distinct DHN, DOPA and pyomelanin pathways were identified. The MAT (MAting Type) locus and other sex-related genes were recognized in all 23 black fungi. Members of the asexual genera Fonsecaea and Cladophialophora appear to be heterothallic with a single copy of either MAT-1-1 or MAT-1-2 in each individual. All Capronia species are homothallic as both MAT1-1 and MAT1-2 genes were found in each single genome. The genomic synteny of the MAT-locus flanking genes (SLA2-APN2-COX13) is not conserved in black fungi as is commonly observed in Eurotiomycetes, indicating a unique genomic context for MAT in those species. The heterokaryon (het) genes expansion associated with the low selective pressure at the MAT-locus suggests that a parasexual cycle may play an important role in generating diversity among those fungi.

2.
Braz J Med Biol Res ; 50(1): e5658, 2017 Jan 05.
Article de Anglais | MEDLINE | ID: mdl-28076454

RÉSUMÉ

Chitinases are hydrolases that degrade chitin, a polymer of N-acetylglucosamine linked ß(1-4) present in the exoskeleton of crustaceans, insects, nematodes and fungal cell walls. A metagenome fosmid library from a wastewater-contaminated soil was functionally screened for chitinase activity leading to the isolation and identification of a chitinase gene named metachi18A. The metachi18A gene was subcloned and overexpressed in Escherichia coli BL21 and the MetaChi18A chitinase was purified by affinity chromatography as a 6xHis-tagged fusion protein. The MetaChi18A enzyme is a 92-kDa protein with a conserved active site domain of glycosyl hydrolases family 18. It hydrolyses colloidal chitin with an optimum pH of 5 and temperature of 50°C. Moreover, the enzyme retained at least 80% of its activity in the pH range from 4 to 9 and 98% at 600 mM NaCl. Thin layer chromatography analyses identified chitobiose as the main product of MetaChi18A on chitin polymers as substrate. Kinetic analysis showed inhibition of MetaChi18A activity at high concentrations of colloidal chitin and 4-methylumbelliferyl N,N'-diacetylchitobiose and sigmoid kinetics at low concentrations of colloidal chitin, indicating a possible conformational change to lead the chitin chain from the chitin-binding to the catalytic domain. The observed stability and activity of MetaChi18A over a wide range of conditions suggest that this chitinase, now characterized, may be suitable for application in the industrial processing of chitin.


Sujet(s)
Chitine/génétique , Chitinase/génétique , Banque de gènes , Métagénome/génétique , Chitine/composition chimique , Chitinase/composition chimique , Chromatographie en phase liquide à haute performance , Escherichia coli , Expression des gènes/génétique , Vecteurs génétiques , Concentration en ions d'hydrogène , Spécificité du substrat
3.
Braz J Med Biol Res ; 50(1): e5492, 2017 Jan 16.
Article de Anglais | MEDLINE | ID: mdl-28099582

RÉSUMÉ

The conventional method for quantification of polyhydroxyalkanoates based on whole-cell methanolysis and gas chromatography (GC) is laborious and time-consuming. In this work, a method based on flow cytometry of Nile red stained bacterial cells was established to quantify poly-3-hydroxybutyrate (PHB) production by the diazotrophic and plant-associated bacteria, Herbaspirillum seropedicae and Azospirillum brasilense. The method consists of three steps: i) cell permeabilization, ii) Nile red staining, and iii) analysis by flow cytometry. The method was optimized step-by-step and can be carried out in less than 5 min. The final results indicated a high correlation coefficient (R2=0.99) compared to a standard method based on methanolysis and GC. This method was successfully applied to the quantification of PHB in epiphytic bacteria isolated from rice roots.


Sujet(s)
Azospirillum brasilense/métabolisme , Cytométrie en flux/méthodes , Herbaspirillum/métabolisme , Hydroxy-butyrates/métabolisme , Racines de plante/microbiologie , Polyesters/métabolisme , Microscopie de fluorescence
4.
Genet Mol Res ; 14(3): 10139-44, 2015 Aug 21.
Article de Anglais | MEDLINE | ID: mdl-26345950

RÉSUMÉ

The purpose of the present study was to functionally evaluate the influence of superoxide radical-generating compounds on the heterologous induction of a predicted promoter region of open reading frames for paraquat-inducible genes (pqi genes) revealed during genome annotation analyses of the Chromobacterium violaceum bacterium. A 388-bp fragment corresponding to a pqi gene promoter of C. violaceum was amplified using specific primers and cloned into a conjugative vector containing the Escherichia coli lacZ gene without a promoter. Assessments of the expression of the ß-galactosidase enzyme were performed in the presence of menadione (MEN) and phenazine methosulfate (PMS) compounds at different final concentrations to evaluate the heterologous activation of the predicted promoter region of interest in C. violaceum induced by these substrates. Under these experimental conditions, the MEN reagent promoted highly significant increases in the expression of the ß-galactosidase enzyme modulated by activating the promoter region of the pqi genes at all concentrations tested. On the other hand, significantly higher levels in the expression of the ß-galactosidase enzyme were detected exclusively in the presence of the PMS reagent at a final concentration of 50 µg/mL. The findings described in the present study demonstrate that superoxide radical-generating compounds can activate a predicted promoter DNA motif for pqi genes of the C. violaceum bacterium in a dose-dependent manner.


Sujet(s)
Chromobacterium/génétique , Régulation de l'expression des gènes bactériens/effets des médicaments et des substances chimiques , Gènes bactériens , Paraquat/toxicité , Régions promotrices (génétique) , Superoxydes/métabolisme , Chromobacterium/effets des médicaments et des substances chimiques , beta-Galactosidase/métabolisme
5.
Lett Appl Microbiol ; 60(3): 237-41, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25359154

RÉSUMÉ

UNLABELLED: To understand the mechanism of plant-bacterium interaction, it is critical to enumerate epiphytic bacteria colonizing the roots of the host. We developed a new approach, based on flow cytometry, for enumerating these bacteria and used it with rice plants, 7 and 20 days after colonization with Herbaspirillum rubrisubalbicans and Azospirillum brasilense. The results were compared with those obtained with the traditional plate count method. Both methods gave similar numbers of H. rubrisubalbicans associated with rice roots (c. 10(9) CFU g(-1) ). However, flow cytometry gave a number of viable cells of rice-associated A. brasilense that was approx. 10-fold greater than that obtained with the plate count method. These results suggest that the plate count method can underestimate epiphytic populations. Flow cytometry has the additional advantage that it is more precise and much faster than the plate count method. SIGNIFICANCE AND IMPACT OF THE STUDY: Determination of precise number of root-associated bacteria is critical for plant-bacteria interaction studies. We developed a flow cytometry approach for counting bacteria and compared it with the plate count method. Our flow cytometry assay solves two major limitations of the plate count method, namely that requires long incubation times of up to 48 h and only determines culturable cells. This flow cytometry assay provides an efficient, precise and fast tool for enumerating epiphytic cells.


Sujet(s)
Azospirillum brasilense/cytologie , Charge bactérienne/méthodes , Cytométrie en flux/méthodes , Herbaspirillum/cytologie , Oryza/microbiologie , Racines de plante/microbiologie
6.
Int J Immunogenet ; 39(2): 155-60, 2012 Apr.
Article de Anglais | MEDLINE | ID: mdl-22133449

RÉSUMÉ

The receptor for advanced glycation end products (RAGE or AGER), a member of the immunoglobulin superfamily, is involved in pathologies such as atherosclerosis and diabetes. Over 50 SNPs were reported for RAGE, among which were the promoter region polymorphisms -429T>C (rs1800625), -374T>A (rs1800624) and a 63-bp deletion (-407 to -345 bp), all related to increased RAGE expression. Additionally, in the exon 3, a putative site of binding ligands, the missense variation G82S (rs2070600) was associated with skin disorders in patients with diabetes. We have determined allele, genotype and haplotype frequencies of RAGE polymorphisms -429T>C, -374T>A, 63-bp deletion and G82S in Euro-Brazilians (n = 108) and Afro-Brazilians (n = 91), characterized according to the predominant ancestry of the individuals. The allele frequencies for Euro- and Afro-Brazilians were as follows: -429C, 12.5% vs. 12.1% (P = 0.90); -374A, 31.5% vs. 26.2% (P = 0.25); 63del, 0.0% vs. 3.8% (P = 0.004); and 82S, 1.9% vs. 0.6% (P = 0.24). Absolute linkage disequilibrium was found between the promoter polymorphisms -429T>C and -374T>A plus the 63-bp deletion (D'=1.000; P < 0.0001). The haplotype frequencies differed (P = 0.003) between Euro- and Afro-Brazilians. Our results showed that the frequencies of the 63-bp deletion were higher in Afro-Brazilians, while the other analysed polymorphisms were similarly distributed in the studied populations. The -374T>A plus 63-bp deletion polymorphism captures more than 80% of the haplotypic variation in the studied population.


Sujet(s)
Exons , Fréquence d'allèle , Polymorphisme génétique , Régions promotrices (génétique) , Récepteurs immunologiques/génétique , Allèles , Séquence nucléotidique , 38410/génétique , Brésil/ethnologie , Génétique des populations , Techniques de génotypage , Haplotypes , Humains , Déséquilibre de liaison , Récepteur spécifique des produits finaux de glycosylation avancée , Délétion de séquence , 38413/génétique
7.
Exp Parasitol ; 127(2): 429-35, 2011 Feb.
Article de Anglais | MEDLINE | ID: mdl-20971106

RÉSUMÉ

Trypanosoma cruzi is the etiological agent of Chagas disease, an important neglected illness affecting about 12-14 million people in endemic areas of Latin America. The chemotherapy of Chagas disease is quite unsatisfactory mainly due to its poor efficacy especially during the later chronic phase and the considerable well-known side effects. These facts emphasize the need to search for find new drugs. Diamidines and related compounds are minor groove binders of DNA at AT-rich sites and present excellent anti-trypanosomal activity. In the present study, six novel aromatic amidine compounds (arylimidamides and diamidines) were tested in vitro to determine activity against the infective and intracellular stages of T. cruzi, which are responsible for sustaining the infection in the mammalian hosts. In addition, their selectivity and toxicity towards primary cultures of cardiomyocyte were evaluated since these cells represent important targets of infection and inflammation in vivo. The aromatic amidines were active against T. cruzi in vitro, the arylimidamide DB1470 was the most effective compound presenting a submicromolar LD(50) values, good selectivity index, and good activity at 4 °C in the presence of blood constituents. Our results further justify trypanocidal screening assays with these classes of compounds both in vitro and in vivo in experimental models of T. cruzi infection.


Sujet(s)
Amidines/pharmacologie , Trypanocides/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Amidines/composition chimique , Animaux , Maladie de Chagas/traitement médicamenteux , Maladie de Chagas/parasitologie , Relation dose-effet des médicaments , Dose létale 50 , Souris , Myocytes cardiaques/effets des médicaments et des substances chimiques , Myocytes cardiaques/parasitologie , Parasitémie/traitement médicamenteux , Parasitémie/parasitologie , Pentamidine/composition chimique , Pentamidine/pharmacologie , Trypanocides/composition chimique
8.
Cell Tissue Res ; 341(1): 173-80, 2010 Jul.
Article de Anglais | MEDLINE | ID: mdl-20495825

RÉSUMÉ

Apoptosis, type-I of programmed cell death (PCD-I), is not restricted to multicellular organisms since many apoptotic features have been described in different trypanosomatids, including Trypanosoma cruzi. Our present aim was to monitor, by different morphological markers, the occurrence of apoptosis-like death in amastigotes and trypomastigotes of T.cruzi (Y strain) during the infection of heart culture cells. We documented the differential occurrence of PCD-I in amastigotes and trypomastigotes, with distinct death rates noticed between these two parasite-distinct forms. Fluorescence microscopy and flow cytometry analysis using different hall markers of apoptosis (phosphatidylserine exposure, collapse of mitochondrial membrane potential and DNA fragmentation) showed that amastigotes present higher levels of apoptosis-like cell death as compared to trypomastigotes. It is possible that the higher levels of PCD-I in these highly multiplicative forms may contribute to the control of the parasite burden within the host cells. On the other hand, the apoptosis-like occurrence in the infective but non-proliferative stage of the parasite (trypomastigotes) may play a role in parasite evasion mechanisms as suggested for other parasites.


Sujet(s)
Apoptose , Maladie de Chagas/anatomopathologie , Maladie de Chagas/parasitologie , Coeur/parasitologie , Étapes du cycle de vie , Trypanosoma cruzi/croissance et développement , Animaux , Cytométrie en flux , Potentiel de membrane mitochondriale , Microscopie confocale , Microscopie de fluorescence , Myocarde/anatomopathologie , Phosphatidylsérine/métabolisme
9.
Antimicrob Agents Chemother ; 54(5): 2023-31, 2010 May.
Article de Anglais | MEDLINE | ID: mdl-20231395

RÉSUMÉ

From a series of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol screened in vitro against Trypanosoma cruzi, eight (S1 to S8) were selected for in vivo screening by single-dose oral administration (200 mg/kg of body weight) to infected mice at 5 days postinfection (dpi). Based on significant decreases in both parasitemia levels and mortality rates, S2 and S3 were selected for further assays. Despite having no in vivo effect, S1 was included since it was 2-fold more potent against trypomastigotes than megazol in vitro. Trypomastigotes treated with S1, S2, or S3 showed alterations of the flagellar structure and of the nuclear envelope. When assayed on intracellular amastigotes, the selectivity index (SI) for macrophages was in the range of >27 to >63 and for cardiac cells was >32 for S1 and >48 for megazol. In noninfected mice, S1 did not alter the levels of glutamic oxalacetic transaminase (GOT), glutamate pyruvate transaminase (GPT), or urea. S2 led to an increase in GOT, S3 to increases in GOT and GPT, and megazol to an increase in GOT. Infected mice were treated with each derivative at 50 and 100 mg/kg from dpi 6 to 15: S1 did not interfere with the course of infection or reduce the number of inflammatory foci in the cardiac tissue, S2 led to a significant decrease of parasitemia, and S3 decreased mortality. There was no direct correlation between the in vitro effect on trypomastigotes and amastigotes and the results of the treatment in experimental models, as S1 showed a high potency in vitro while, in two different schemes of in vivo treatment, no decrease of parasitemia or mortality was observed.


Sujet(s)
Maladie de Chagas/traitement médicamenteux , Hydrazones/pharmacologie , Thiadiazoles/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Alanine transaminase/sang , Animaux , Antiprotozoaires/composition chimique , Antiprotozoaires/pharmacologie , Aspartate aminotransferases/sang , Poids , Cellules cultivées , Maladie de Chagas/mortalité , Maladie de Chagas/parasitologie , Hydrazones/composition chimique , Techniques in vitro , Concentration inhibitrice 50 , Macrophages péritonéaux/cytologie , Macrophages péritonéaux/parasitologie , Mâle , Souris , Microscopie électronique à balayage , Myocytes cardiaques/cytologie , Myocytes cardiaques/parasitologie , Parasitémie/traitement médicamenteux , Parasitémie/mortalité , Parasitémie/parasitologie , Thiadiazoles/composition chimique , Trypanosoma cruzi/croissance et développement , Trypanosoma cruzi/ultrastructure , Urée/sang
10.
Lett Appl Microbiol ; 48(5): 645-7, 2009 May.
Article de Anglais | MEDLINE | ID: mdl-19228288

RÉSUMÉ

AIMS: To examine stool specimens from children with diarrhea from Paraná State, southern Brazil, for presence of STEC. METHODS AND RESULTS: A PCR screening assay for stx genes was used to examine a loopful of confluent colonies of 306 stool samples cultures. In six (1.96%) of them, DNA fragments of the expected size were observed, and the presence of stx was confirmed by DNA sequencing. Then up to 100 single colonies from each of the six stool cultures were analyzed using the same PCR protocol. However, stx-positive colonies were found only in two of the cultures. The E. coli strains belonged to serotypes O69:H11 and O178:H19, and presented genotypes stx(1)eae ehxA and stx(1) respectively. Shiga toxin production was confirmed using the VTEC Screen Seiken. Except ampicillin, they were susceptible to all the antimicrobials tested. CONCLUSIONS: These results show that STEC may be an important cause of diarrhea in children of Paraná State, and that they are present in low numbers in stools. The strains belonged to serotypes not commonly found associated with STEC and probably present low virulence. SIGNIFICANCE AND IMPACT OF STUDY: These results indicate that molecular methods are required to diagnosis of STEC infections.


Sujet(s)
Diarrhée/microbiologie , Infections à Escherichia coli/microbiologie , Shiga-toxine/métabolisme , Escherichia coli producteur de Shiga-toxine/isolement et purification , Escherichia coli producteur de Shiga-toxine/métabolisme , Brésil , Enfant , Fèces/microbiologie , Femelle , Humains , Mâle , Études prospectives , Shiga-toxine/génétique , Escherichia coli producteur de Shiga-toxine/génétique
11.
Curr Mol Pharmacol ; 1(2): 151-61, 2008 Jun.
Article de Anglais | MEDLINE | ID: mdl-20021429

RÉSUMÉ

Aromatic diamidines and related compounds are DNA minor groove binders that have been screened against a variety of pathogenic microorganisms such as bacteria, fungi and protozoa and show promising results. Parasitic infections are widespread in developing countries and are major contributors to human mortality and morbidity, causing considerable economic hardship. Trypanosomes are unicellular protozoan organisms that cause serious public health problems in developing countries: African trypanosomiasis (sleeping sickness) in Africa, and Chagas' disease, in Latin America. Sleeping sickness, caused by sub-species of Trypanosome brucei (T. brucei gambiense and T. brucei rhodesiense), is a fatal disease if left untreated, with about 60 million people currently at risk. Trypanosoma cruzi is the etiological agent of Chagas' disease, an important parasitic illness that affects nearly 17 million individuals in endemic areas. The fact that the available clinical drugs are expensive, toxic, require long treatment periods, frequently exhibit reduced activity towards certain parasite strains and evolutive stages, and are beginning to show development of resistance, demonstrates the urgent need for the development of new drugs for both pathologies. For some time much attention has been focused on the effect of diamidines (and related compounds) on African trypanosomes. However more recent studies have pointed to their potential activity against T.cruzi. In this review the current therapeutic state of the art of aromatic diamidines and related compounds used against T.brucei and T.cruzi is reviewed with a focus on their potential use as antiparasitic drugs for the treatment of both these important neglected diseases.


Sujet(s)
Pentamidine/usage thérapeutique , Trypanocides/usage thérapeutique , Maladie du sommeil/traitement médicamenteux , Animaux , Maladie de Chagas/traitement médicamenteux , Résistance aux substances , Humains , Pentamidine/composition chimique , Pentamidine/pharmacologie , Trypanocides/composition chimique , Trypanosoma brucei brucei/effets des médicaments et des substances chimiques , Trypanosoma cruzi/effets des médicaments et des substances chimiques
12.
J Clin Pathol ; 61(2): 209-12, 2008 Feb.
Article de Anglais | MEDLINE | ID: mdl-17496190

RÉSUMÉ

BACKGROUND: Mycosis fungoides (MF) is the most common skin lymphoid neoplasm. In initial stages, differential diagnosis of MF from other benign dermal lymphoid infiltrates (BDLI) may be impossible on morphological basis alone. In previous studies, only deletion of CD7 in MF proved to be of diagnostic help, but not the ratio between immunoexpression of CD4 and CD8. METHODS: 30 cases of MF and 11 cases of BDLI were analysed, in order to compare morphometric parameters, which could be of diagnostic aid. As CD7 is frequently deleted in MF, immunohistochemical detection of T-cells was made using an antibody to CD3. Images of 100 CD3-positive cells per case in both groups were captured and analysed using a simple computer program for nuclear perimeter, area, diameter and nuclear contour index. RESULTS: All parameters showed statistically significant higher values for MF. Area was the variable with the strongest discriminating power between the two groups of patients. Thus even if morphological evaluation is not accurate to distinguish benign versus malignant dermal lymphoid infiltrates, due to the variability of size and shape of these cells, a more sensitive method promptly shows this difference. CONCLUSION: Results suggest that morphometry of CD3-positive lymphoid cells may add valuable information in the differential diagnosis of MF and benign dermatoses.


Sujet(s)
Marqueurs biologiques tumoraux/métabolisme , Antigènes CD3/métabolisme , Mycosis fongoïde/diagnostic , Tumeurs cutanées/diagnostic , Antigènes néoplasiques/métabolisme , Noyau de la cellule/anatomopathologie , Diagnostic différentiel , Humains , Mycosis fongoïde/ultrastructure , Études rétrospectives , Sensibilité et spécificité , Maladies de la peau/diagnostic , Tumeurs cutanées/ultrastructure
13.
Exp Parasitol ; 118(3): 331-7, 2008 Mar.
Article de Anglais | MEDLINE | ID: mdl-18028912

RÉSUMÉ

A2M is a broad spectrum proteinase inhibitor and cytokine carrier, besides presenting anti-apoptotic activity through the binding to its receptor, LRP. During Trypanosoma cruzi infection, apoptosis of host cells and intracellular parasites is commonly observed both in vivo and in vitro. Since plasma as well as tissue A2M levels are increased in both murine and human acute T. cruzi infection, we evaluated the possible role of A2M (its methylamine transformed Fast form-A2M-F) in regulating apoptotic events in peritoneal macrophages and cardiomyocytes during in vitro interaction with the parasite. Our data showed that DNA fragmentation (a hallmark of apoptosis) of both host cells and parasites was inhibited by A2M-F. Impaired apoptosis was also noted when A2M-F was added to the cultures maintained under serum deprivation. In addition, macrophages from C57/BL6 mice, known to display higher LRP levels as compared to those of C3H lineage, displayed higher reduction in the apoptotic levels during the A2M-F treatment.


Sujet(s)
Apoptose/physiologie , Macrophages péritonéaux/parasitologie , Myocytes cardiaques/parasitologie , Trypanosoma cruzi/pathogénicité , alpha-Macroglobulines/physiologie , Animaux , Apoptose/effets des médicaments et des substances chimiques , Fragmentation de l'ADN/effets des médicaments et des substances chimiques , Humains , Méthode TUNEL , Protéines apparentées au récepteur LDL/métabolisme , Macrophages péritonéaux/cytologie , Macrophages péritonéaux/effets des médicaments et des substances chimiques , Souris , Souris de lignée C3H , Souris de lignée C57BL , Myocytes cardiaques/cytologie , Myocytes cardiaques/effets des médicaments et des substances chimiques , alpha-Macroglobulines/pharmacologie
14.
Antimicrob Agents Chemother ; 51(11): 3803-9, 2007 Nov.
Article de Anglais | MEDLINE | ID: mdl-17698624

RÉSUMÉ

Aromatic diamidines represent a class of DNA minor groove-binding ligands that exhibit high levels of antiparasitic activity. Since the chemotherapy for Chagas' disease is still an unsolved problem and previous reports on diamidines and related analogues show that they have high levels of activity against Trypanosoma cruzi infection both in vitro and in vivo, our present aim was to evaluate the cellular effects in vitro of three reversed amidines (DB889, DB702, and DB786) and one diguanidine (DB711) against both amastigotes and bloodstream trypomastigotes of T. cruzi, the etiological agent of Chagas' disease. Our data show that the reversed amidines have higher levels of activity than the diguanidine, with the order of trypanocidal activities being as follows: DB889 > DB702 > DB786 > DB711. Transmission electron microscopy analysis showed that the reversed amidines induced many alterations in the nuclear morphology, swelling of the endoplasmic reticulum and Golgi structures, and consistent damage in the mitochondria and kinetoplasts of the parasites. Interestingly, in trypomastigotes treated with the reversed amidine DB889, multiple axoneme structures (flagellar microtubules) were noted. Flow cytometry analysis confirmed that the treated parasites presented an important loss of the mitochondrial membrane potential, as revealed by a decrease in rhodamine 123 fluorescence. Our results show that the reversed amidines have promising activities against the relevant mammalian forms of T. cruzi and display high trypanocidal effects at very low doses. This is especially the case for DB889, which merits further in vivo evaluation.


Sujet(s)
Amidines/pharmacologie , Trypanocides/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Trypanosoma cruzi/ultrastructure , Amidines/composition chimique , Animaux , Chlorocebus aethiops , Relation dose-effet des médicaments , Furanes/pharmacologie , Guanidine/analogues et dérivés , Guanidine/pharmacologie , Concentration inhibitrice 50 , Microscopie électronique à transmission , Structure moléculaire , Tests de sensibilité parasitaire , Relation structure-activité , Trypanocides/composition chimique , Cellules Vero
15.
Lett Appl Microbiol ; 44(6): 607-12, 2007 Jun.
Article de Anglais | MEDLINE | ID: mdl-17576221

RÉSUMÉ

AIMS: To investigate the prevalence and characteristics of Shiga toxin-producing Escherichia coli (STEC) in cattle from Paraná State, southern Brazil. METHODS AND RESULTS: One hundred and seven faeces cattle samples were cultured on Sorbitol-MacConkey agar. Escherichia coli colonies were tested for production of Shiga toxin using Vero-cell assay. A high prevalence (57%) of STEC was found. Sixty-four STEC were serotyped and examined for the presence of stx(1), stx(2), eae, ehxA and saa genes and stx(2) variants. The isolates belonged to 31 different serotypes, of which three (O152:H8, O175:H21 and O176:H18) had not previously been associated with STEC. A high prevalence of stx(2)-type genes was found (62 strains, 97%). Variant forms found were stx(2), stx(2c), stx(2vhb), stx(2vO111v/OX393) and a form nonclassifiable by PCR-RFLP. The commonest genotypes were stx(2)ehxA saa and stx(1)stx(2)ehxA saa. CONCLUSIONS: A high frequency of STEC was observed. Several strains belong to serotypes previously associated with human disease and carry stx(2) and other virulence factors, thus potentially representing a risk to human health. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first study of STEC in Paraná State, and its findings emphasize the need for proper cattle handling to prevent human contamination.


Sujet(s)
Bovins/microbiologie , Escherichia coli/classification , Escherichia coli/isolement et purification , Shiga-toxines/biosynthèse , Animaux , Brésil , Chlorocebus aethiops , Escherichia coli/pathogénicité , Fèces/microbiologie , Génotype , Viande , Phénotype , Réaction de polymérisation en chaîne , Polymorphisme de restriction , Sérotypie , Shiga-toxines/génétique , Cellules Vero , Virulence/génétique
16.
Parasitology ; 133(Pt 1): 75-9, 2006 Jul.
Article de Anglais | MEDLINE | ID: mdl-16563202

RÉSUMÉ

Two aromatic diamidines, furamidine (DB75) and its phenyl-substituted analogue (DB569), which exhibit trypanocidal activity, were assayed against Trypanosoma cruzi and were found to induce apoptosis-like death characteristics such as nuclear DNA condensation and fragmentation, decreased mitochondrial membrane potential and phosphatidylserine exposure. DB569 displays superior trypanocidal activity compared to furamidine and also had higher ability to induce apoptosis-like death in treated parasites. The present results showing apoptosis-like death in T. cruzi after treatment with both DB75 and DB569 make important contributions to the understanding of the mechanisms of the aromatic diamidines, which represent promising trypanocidal compounds.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Pentamidine/pharmacologie , Trypanocides/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Animaux , Benzamidines/composition chimique , Benzamidines/pharmacologie , Fragmentation de l'ADN , Relation dose-effet des médicaments , Cytométrie en flux , Souris , Tests de sensibilité parasitaire , Pentamidine/composition chimique , Relation structure-activité , Trypanosoma cruzi/cytologie , Trypanosoma cruzi/physiologie
17.
Expert Opin Investig Drugs ; 14(8): 957-72, 2005 Aug.
Article de Anglais | MEDLINE | ID: mdl-16050790

RÉSUMÉ

Parasitic infections are widespread in developing countries and frequently associated with immunocompromised patients in developed countries. Consequently, such infections are responsible for a significant amount of human mortality, morbidity and economic hardship. A growing consensus has identified the urgent need for the development of new antiparasitic compounds, mostly due to the large number of drug-resistant parasites and the fact that currently available drugs are expensive, highly toxic, require long treatment regimens and frequently exhibit significantly reduced activity towards certain parasite strains and evolutive stages. In this context, the activity of aromatic diamidines has been explored against a widespread range of micro-organisms, and the authors' present aim is to review the current status of chemotherapy with these compounds against human parasitic infections.


Sujet(s)
Antiparasitaires/usage thérapeutique , Médicaments en essais cliniques/usage thérapeutique , Maladies parasitaires/traitement médicamenteux , Pentamidine/analogues et dérivés , Pentamidine/usage thérapeutique , Animaux , Antiparasitaires/composition chimique , Médicaments en essais cliniques/composition chimique , Humains , Maladies parasitaires/parasitologie
18.
J Eur Acad Dermatol Venereol ; 18(5): 538-42, 2004 Sep.
Article de Anglais | MEDLINE | ID: mdl-15324388

RÉSUMÉ

INTRODUCTION: 2-Chlorodeoxyadenosine (cladribine or 2-CdA) is a purine analogue that has been used successfully in hairy cell leukaemia (HCL). Moreover, it has been increasingly used to treat chronic lymphoproliferative syndromes and paediatric acute myeloid leukaemia. Cutaneous side-effects associated with this drug have seldom been described in cases of HCL. PATIENTS AND METHODS: We describe three patients with chronic lymphocytic leukaemia that presented generalized skin eruptions after treatment with 2-CdA. RESULTS: All patients had advanced disease, receiving 2-CdA as a second or third line chemotherapy. Skin lesions were severe and chemotherapy had to be discontinued. Histological examination of skin biopsies showed an eosinophil-rich infiltrate with flame figures, similar to what is observed in Wells' syndrome (eosinophilic cellulitis). Corticosteroids were effective to control the eruptions. CONCLUSIONS: Cutaneous adverse reactions associated with 2-CdA have seldom been observed in the treatment of HCL. However, as this purine analogue has been used in more advanced cases these may be more frequent and severe. The pathophysiology of these lesions is unclear, but it is probably related to drug-induced change in T-cell imbalance in severely immunosuppressed patients.


Sujet(s)
Antinéoplasiques/effets indésirables , Chloro-2 désoxyadénosine/effets indésirables , Toxidermies/diagnostic , Exanthème/diagnostic , Leucémie chronique lymphocytaire à cellules B/traitement médicamenteux , Sujet âgé , Antinéoplasiques/administration et posologie , Chloro-2 désoxyadénosine/administration et posologie , Diagnostic différentiel , Toxidermies/étiologie , Toxidermies/anatomopathologie , Exanthème/induit chimiquement , Exanthème/anatomopathologie , Femelle , Humains , Adulte d'âge moyen
19.
Biochem Pharmacol ; 68(4): 593-600, 2004 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-15276066

RÉSUMÉ

Furamidine (DB75) and related unfused aromatic diamidines have proven useful for the treatment of parasitic infections. These compounds were primarily developed to combat infections by Pneumocystis carinii and African trypanosomes but they are also active against other parasites. Here we have investigated the in vitro effects of DB75 and its phenyl-substituted analog DB569 on two kinetoplastid haemoflagellates Trypanosomatidae: Trypanosoma cruzi and Leishmania (L) amazonensis. The phenyl-amidine compound DB569 has equivalent DNA binding properties compared to DB75 but it was selected on the basis of its distinct tumor cell distribution properties. We found that DB569 is significantly more potent than DB75 at reducing the proliferation of the parasites, using either isolated parasites in cultures or with cardiomyocyte and macrophage host cells. DB569 is effective towards the intracellular forms of T. cruzi (IC(50) in the low-micromolar range) and it exhibits trypanocidal dose-dependent effects against trypomastigote forms of T. cruzi parasites obtained from the Y strain and Dm28c clone, which belong to two different biodemes. Fluorescence microscopy experiments indicated that both diamidines were mostly localized in the nucleus of the mammalian host cells and within the nuclei and kinetoplast of the parasites. Electron microscopy studies showed that the treatment of the parasites with DB75 and DB569 induces important alterations of the parasite nucleus and kinetoplast, at sites where their DNA target is localized. Altogether, the data suggest that the phenyl-substituted furamidine analogue DB569 is a potential new candidate for the treatment of the Chagas' disease and Leishmaniasis.


Sujet(s)
Antiprotozoaires/pharmacologie , Benzamidines/pharmacologie , Leishmania/effets des médicaments et des substances chimiques , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Animaux , Antiprotozoaires/composition chimique , Benzamidines/composition chimique , Tests de sensibilité parasitaire , Relation structure-activité , Trypanocides/composition chimique , Trypanocides/pharmacologie
20.
Vet Parasitol ; 122(1): 67-78, 2004 Jun 10.
Article de Anglais | MEDLINE | ID: mdl-15158557

RÉSUMÉ

Humoral immune response of water buffalo naturally infected with Toxocara vitulorum was monitored using three different antigens of this parasite in serum and colostrum of buffalo cows and calves. Soluble extract (Ex) and excretory/secretory (ES) larval antigens and perienteric fluid antigen (Pe) of adult T. vitulorum were used to measure the antibody levels by an indirect ELISA. Serum of 7-12 buffalo cows for the first 365 days and colostrum of the same number of buffalo cows for the first 60 days of parturition, and serum of 8-10 buffalo calves for the first 365 days after birth were assayed. The ELISA detected antibodies against all three T. vitulorum antigens in the colostrum and serum of 100% of buffalo cows and calves examined. The highest antibody levels against Ex, ES and Pe antigens were detected in the buffalo cow sera during the perinatal period and were maintained at high levels through 300 days after parturition. On the other hand, colostrum antibody concentrations of all three antigens were highest on the first day post-parturition, but decreased sharply during the first 15 days. Concomitantly to the monitoring of immune response, the parasitic status of the calves was also evaluated. In calves, antibodies passively acquired were at the highest concentrations 24 h after birth and remained at high levels until 45 days coincidentally with the peak of T. vitulorum infection. The rejection of the worms by the calves occurred simultaneously with the decline of antibody levels, which reached their lowest levels between 76 and 150 days. Thereafter, probably because of the presence of adults/larvae stimulation, the calves acquired active immunity and the antibodies started to increase slightly in the serum and plateaued between the days 211 and 365. All three antigens were detected by the serum antibodies of buffalo calves; however, the concentration of anti-Pe antibody was higher than anti-EX and anti-ES, particularly after 90 days of age. By conclusion, the buffalo cows develop immunity and keep high levels of antibodies against T. vitulorum-Ex, ES and Pe antigens and these antibodies are transferred to their calves through the colostrum. This passively acquired immunity does not protect the calves against the acquisition of the infection, but these antibodies, passively or actively acquired, may have an important role during worm rejection by the calves and prevention of intestinal reinfection.


Sujet(s)
Buffles/immunologie , Buffles/parasitologie , Toxocara/immunologie , Toxocarose/immunologie , Animaux , Animaux nouveau-nés , Anticorps antihelminthe/sang , Colostrum/parasitologie , Test ELISA/méthodes , Test ELISA/médecine vétérinaire , Fèces/parasitologie , Femelle , Immunoglobuline G/sang , Études longitudinales , Mâle , Lait/parasitologie , Numération des oeufs de parasites/médecine vétérinaire , Toxocarose/sang , Toxocarose/parasitologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE